[Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock].
Demidov. S V SV; Kostromin. A N AN; Kuĭbeda. V V VV; Chernaia. I V IV; Borovok. M I MI
Key Findings
- Sensitization of animals lowers the cAMP/cGMP ratio in spleen lymphocytes.
- Anaphylactic shock brings the cAMP/cGMP ratio back to normal levels.
- Thymogen, thymalin and vilosen boost phosphodiesterase activity, altering cyclic nucleotide breakdown in both sensitized and anaphylactic animals.
Practical Outcomes
- The findings hint that thymogen could influence immune signaling pathways, but there’s no dosage, safety, or protocol information for people. Biohackers should treat this as early‑stage animal data and wait for human studies before considering supplementation.
Summary
In guinea‑pig experiments, thymogen‑related peptides changed the balance of cellular signaling molecules (cAMP and cGMP) during allergic reactions, but the work is purely mechanistic and done in animals, so it doesn’t give clear guidance for human use.
Abstract
It is established that the effect of thymus-derived species is connected with the cyclic nucleotide system. The action of thymus-derived immunocorrectors (thymalin, thymagen, vilosen) on catabolic processes of cyclic nucleotides has been observed under conditions of anaphylaxy and sensibilization. They show that sensibilization of the animal is bound up with a decrease of the cAMP/cGMP ratio. Anaphylaxis induces levelling of the cAMP/cGMP ratio up to the reference level. So, activity of enzymes of cyclic nucleotide catabolism grows due to the influence of thymogen, thymalin and vilosen in lymphocytes of sensibilized guinea pigs and tends to an increase in lymphocytes of anaphylaxis-treated animals.
Study Information
pubmed
1991